AbstractIn this study, we examined the role of aldose reductase (AR) in regulating the cytotoxic effects of TNF-α on human umbilical vein endothelial cells. Inhibition of AR by sorbinil or tolrestat prevented TNF-α-induced increase in Bax and Bak and the downregulation of Bcl-2. Inhibition of AR abrogated AP-1 DNA binding activity and prevented the activation of caspase-3, JNK, and p38 MAPK in cells stimulated by TNF-α. Exposure to TNF-α also induced apoptotic cell death, which was attenuated by AR inhibition or antisense ablation. These observations suggest that AR is a critical regulator of TNF-α-induced apoptotic signaling in endothelial cells
Recent studies suggest that increased aldose reductase (AR) activity plays an important role in isch...
Necroptosis is a programmed cell death pathway that is implicated in a variety of human diseases. In...
Aldose reductase (AR) has been implicated in the pathogenesis of diabetic complications, although th...
AbstractIn this study, we examined the role of aldose reductase (AR) in regulating the cytotoxic eff...
Exaggerated inflammatory responses and the resultant increases in alveolar-capillary permeability un...
In the past years aldose reductase (AKR1B1; AR) is thought to be involved in the pathogenesis of sec...
AbstractEpalrestat (EPS) is the only aldose reductase inhibitor that is currently available for the ...
To determine the role of the polyol metabolizing pathway under hyperglycemic conditions, the effects...
Systemic inflammatory response syndrome is a fatal disease because of multiple organ failure. Acute ...
Abstract Background Uric acid ...
Epalrestat (EPS) is the only aldose reductase inhibitor that is currently available for the treatmen...
Objective—There are several pathways that mediate the aberrant metabolism of glucose and that might ...
The occurrence of Alzheimer’s disease has been associated with the accumulation of beta-amyloid (β-a...
Diabetes mellitus (DM) is a complex metabolic disorder arising from lack of insulin production or in...
<div><p>Hepatic aldose reductase (AR) expression is known to be induced in liver diseases, including...
Recent studies suggest that increased aldose reductase (AR) activity plays an important role in isch...
Necroptosis is a programmed cell death pathway that is implicated in a variety of human diseases. In...
Aldose reductase (AR) has been implicated in the pathogenesis of diabetic complications, although th...
AbstractIn this study, we examined the role of aldose reductase (AR) in regulating the cytotoxic eff...
Exaggerated inflammatory responses and the resultant increases in alveolar-capillary permeability un...
In the past years aldose reductase (AKR1B1; AR) is thought to be involved in the pathogenesis of sec...
AbstractEpalrestat (EPS) is the only aldose reductase inhibitor that is currently available for the ...
To determine the role of the polyol metabolizing pathway under hyperglycemic conditions, the effects...
Systemic inflammatory response syndrome is a fatal disease because of multiple organ failure. Acute ...
Abstract Background Uric acid ...
Epalrestat (EPS) is the only aldose reductase inhibitor that is currently available for the treatmen...
Objective—There are several pathways that mediate the aberrant metabolism of glucose and that might ...
The occurrence of Alzheimer’s disease has been associated with the accumulation of beta-amyloid (β-a...
Diabetes mellitus (DM) is a complex metabolic disorder arising from lack of insulin production or in...
<div><p>Hepatic aldose reductase (AR) expression is known to be induced in liver diseases, including...
Recent studies suggest that increased aldose reductase (AR) activity plays an important role in isch...
Necroptosis is a programmed cell death pathway that is implicated in a variety of human diseases. In...
Aldose reductase (AR) has been implicated in the pathogenesis of diabetic complications, although th...